Geode Capital Management’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $251K | Sell |
369,660
-9,356
| -2% | -$6.36K | ﹤0.01% | 3795 |
|
|
2025
Q1 | $275K | Buy |
379,016
+20,594
| +6% | +$14.9K | ﹤0.01% | 3748 |
|
|
2024
Q4 | $342K | Buy |
358,422
+20,230
| +6% | +$19.3K | ﹤0.01% | 3720 |
|
|
2024
Q3 | $266K | Buy |
338,192
+155,337
| +85% | +$122K | ﹤0.01% | 3808 |
|
|
2024
Q2 | $173K | Buy |
182,855
+98,029
| +116% | +$92.9K | ﹤0.01% | 3967 |
|
|
2024
Q1 | $91.7K | Hold |
84,826
| – | – | ﹤0.01% | 4186 |
|
|
2023
Q4 | $46.7K | Hold |
84,826
| – | – | ﹤0.01% | 4367 |
|
|
2023
Q3 | $179K | Buy |
84,826
+100
| +0.1% | +$211 | ﹤0.01% | 4027 |
|
|
2023
Q2 | $222K | Hold |
84,726
| – | – | ﹤0.01% | 3999 |
|
|
2023
Q1 | $269K | Hold |
84,726
| – | – | ﹤0.01% | 3906 |
|
|
2022
Q4 | $227K | Buy |
84,726
+1,137
| +1% | +$3.05K | ﹤0.01% | 4030 |
|
|
2022
Q3 | $243K | Hold |
83,589
| – | – | ﹤0.01% | 4092 |
|
|
2022
Q2 | $244K | Sell |
83,589
-58,121
| -41% | -$170K | ﹤0.01% | 4144 |
|
|
2022
Q1 | $1M | Buy |
141,710
+7,525
| +6% | +$53.2K | ﹤0.01% | 3621 |
|
|
2021
Q4 | $2.15M | Buy |
+134,185
| New | +$2.15M | ﹤0.01% | 3335 |
|